Aberrant expression of the microtubule-associated protein tau is an independent prognostic feature in prostate cancer

BACKGROUND: Microtubule-associated protein Tau (MAPT) overexpression has been linked to poor prognosis and decreased response to taxane-based therapies in several cancer types, but its relevance in prostate cancer is unknown. METHODS: In this study, MAPT expression was analyzed by immunohistochemist...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC Cancer
Hauptverfasser: Schroeder, Cornelia, Grell, Jan, Hube-Magg, Claudia, Kluth, Martina, Lang, Dagmar, Simon, Ronald, Höflmayer, Doris, Minner, Sarah, Burandt, Eike, Clauditz, Till S., Büscheck, Franziska, Jacobsen, Frank, Huland, Hartwig, Graefen, Markus, Schlomm, Thorsten, Sauter, Guido, Steurer, Stefan
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6397474/
https://ncbi.nlm.nih.gov/pubmed/30823906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5390-1
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge